Host control of HIV-1 parasitism in T cells by the nuclear factor of activated T cells

Cell

Volumn 95, Issue 5, 1998, Pages 595-604

  Kinoshita, Shigemi ^a   Chen, Benjamin K ^b,c   Kaneshima, Hideto ^d   Nolan, Garry P ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c ROCKEFELLER UNIVERSITY   (United States)

^d NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; NUCLEAR FACTOR; TACROLIMUS; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NF ATC; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CONTROLLED STUDY; HELPER CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; PROVIRUS; T LYMPHOCYTE ACTIVATION; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0032567042     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)81630-X     Document Type: Article

References (40)

1. Agarwal, M., Austin, T.W., Morel, F., Chen, J., Bohnlein, E., and Plavec, I. (1998). Scaffold attachment region-mediated enhancement of retroviral vector expression in primary T cells. J Virol. 72, 3720-3728.
2. Barre Sinoussi, F., Chermann, J.C., Rey, F., Nugeyre, M.T., Chamaret, S., Gruest, J., Dauguet, C., Axler, B.C., Vezinet, B.F., Rouzioux, C., Rozenbaum, W., and Montagnier, L. (1983). Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 220, 868-871.
3. Borvak, J., Chou, C.S., Van Dyke, G., Rosenwirth, B., Vitetta, E.S., and Ramilo, O. (1996). The use of cyclosporine, FK506, and SDZ NIM811 to prevent CD25-quiescent peripheral blood mononuclear cells from producing human immunodeficiency virus. J. Infect. Dis. 174, 850-853.
4. Bukrinsky, M.I., Stanwick, T.L., Dempsey, M.P., and Stevenson, M. (1991). Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection. Science 254, 423-427.
5. Bukrinsky, M.I., Sharova, N., Dempsey, M.P., Stanwick, T.L., Bukrinskaya, A.G., Haggerty, S., and Stevenson, M. (1992). Active nuclear import of human immunodeficiency virus type 1 preintegration complexes. Proc. Natl. Acad. Sci. USA 89, 6580-6584.
6. Chen, B.K., Feinberg, M.B., and Baltimore, D. (1997). The KB sites in the human immunodeficiency virus type 1 long terminal repeat enhance virus replication yet are not absolutely required for viral growth. J. Virol. 71, 5495-5504.
7. Flanagan, W.M., Corthesy, B., Bram, R.J., and Crabtree, G.R. (1991). Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A. Nature 352, 803-807.
8. Folks, T., Kelly, J., Benn, S., Kinter, A., Justement, J., Gold, J., Redfield, R., Sell, K.W., and Fauci, A.S. (1986). Susceptibility of normal human lymphocytes to infection with HTLV-III/LAV. J. Immunol. 136, 4049-4053.
9. Franke, E.K., Yuan, H.E., and Luban, J. (1994). Specific incorporation of cyclophilin A into HIV-1 virions. Nature 372, 359-362.
10. Gallardo, H.F., Tan, C., Ory, D., and Sadelain, M. (1997). Recombinant retroviruses pseudotyped with the vesicular stomatitis virus G glycoprotein mediate both stable gene transfer and pseudotransduction in human peripheral blood lymphocytes. Blood 90, 952-957.
11. Gallay, P., Swingler, S., Aiken, C., and Trono, D. (1995). HIV-1 infection of nondividing cells: C-terminal tyrosine phosphorylation of the viral matrix protein is a key regulator. Cell 80, 379-388.
12. Gallay, P., Hope, T., Chin, D., and Trono, D. (1997). HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway. Proc. Natl. Acad. Sci. USA 94, 9825-9830.
13. Gallo, R.C., Salahuddin, S.Z., Popovic, M., Shearer, G.M., Kaplan, M., Haynes, B.F., Palker, T.J., Redfield, R., Oleske, J., Safai, B., et al. (1984). Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science 224, 500-503.
14. Grilli, M., Chiu, J.J., and Lenardo, M.J. (1993). NF-κB and Rel:participants in a multiform transcriptional regulatory system. Int. Rev. Cytol. 143, 1-62.
15. Heinzinger, N.K., Bukinsky, M.I., Haggerty, S.A., Ragland, A.M., Kewalramani, V., Lee, M.A., Gendelman, H.E., Ratner, L., Stevenson, M., and Emerman, M. (1994). The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc. Natl. Acad. Sci. USA 91, 7311-7315.
16. Jain, J., Miner, Z., and Rao, A. (1993). Analysis of the preexisting and nuclear forms of nuclear factor of activated T cells. J. Immunol. 151, 837-848.
17. Karpas, A., Lowdell, M., Jacobson, S.K., and Hill, F. (1992). Inhibition of human immunodeficiency virus and growth of infected T cells by the immunosuppressive drugs cyclosporin A and FK 506. Proc. Natl. Acad. Sci. USA 89, 8351-8355.
18. Kinoshita, S., Su, L., Amano, M., Timmerman, L.A., Kaneshima, H., and Nolan, G.P. (1997). The T cell activation factor NF-ATc positively regulates HIV-1 replication and gene expression in T cells. Immunity 6, 235-244.
19. Korin, Y.D., and Zack, J.A. (1998). Progression to the G1b phase of the cell cycle is required for completion of human immunodeficiency virus type 1 reverse transcription in T cells. J. Virol. 72, 3161-3168.
20. Langhoff, E., Terwilliger, E.F., Bos, H.J., Kalland, K.H., Poznansky, M.C., Bacon, O.M., and Haseltine, W.A. (1991). Replication of human immunodeficiency virus type 1 in primary dendritic cell cultures. Proc. Natl. Acad. Sci. USA 88, 7998-8002.
21. Li, G., Simm, M., Potash, M.J., and Volsky, D.J. (1993). Human immunodeficiency virus type 1 DNA synthesis, integration, and efficient viral replication in growth-arrested T cells. J. Virol. 67, 3969-3977.
22. Liu, J., Farmer, J.D., Jr., Lane, W.S., Friedman, J., Weissman, I., and Schreiber, S.L. (1991). Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66, 807-815.
23. Moore, J.P. (1997). Coreceptors: implications for HIV pathogenesis and therapy. Science 276, 51-52.
24. Nabel, G., and Baltimore, D. (1987). An inducible transcription factor activates expression of human immunodeficiency virus in T cells [published erratum appears in Nature 1990 Mar 8; 344(6262):178]. Nature 326, 711-713.
25. Nolan, G.P. (1994). NF-AT-AP-1 and Rel-bZIP: hybrid vigorand binding under the influence. Cell 77, 795-798.
26. Northrop, J.P., Ho, S., Chen, N.L., Thomas, D.J., Timmerman, L.A., Nolan, G.P., Admon, A., and Crabtree, G.R. (1994). NF-AT components define a family of transcription factors targeted in T-cell activation. Nature 369, 497-502.
27. Rao, A., Luo, C., and Hogan, P.G. (1997). Transcription factors of the NFAT family: regulation and function. Annu. Rev. Immunol. 15, 707-747.
28. Roe, T., Reynolds, T.C., Yu, G., and Brown, P.O. (1993). Integration of murine leukemia virus DNA depends on mitosis. EMBO. J. 12, 2099-2108.
29. Spina, C.A., Guatelli, J.C., and Richman, D.D. (1995). Establishment of a stable, inducible form of human immunodeficiency virus type 1 DNA in quiescent CD4 lymphocytes in vitro. J. Virol. 69, 2977-2988.
30. Stevenson, M., Stanwick, T.L., Dempsey, M.P., and Lamonica, C.A. (1990). HIV-1 replication is controlled at the level of T cell activation and proviral integration. EMBO J. 9, 1551-1560.
31. Thali, M., Bukovsky, A., Kondo, E., Rosenwirth, B., Walsh, C.T., Sodroski, J., and Gottlinger, H.G. (1994). Functional association of cyclophilin A with HIV-1 virions. Nature 372, 363-365.
32. Thomson, A.W., and Bonham, C.A. (1995). Inhibition of T lymphocyte activation and apoptotic cell death by cyclosporin A and tacrolimus (FK506). Its relevance to therapy of HIV infection. Adv. Exp. Med. Biol. 374, 211-216.
33. Toba, K., Winton, E.F., Koike, T., and Shibata, A. (1995). Simultaneous three-color analysis of the surface phenotype and DNA-RNA quantitation using 7-amino-actinomycin D and pyronin Y. J Immunol. Methods 182, 193-207.
34. Vandekerckhove, B.A., Namikawa, R., Bacchetta, R., and Roncarolo, M.G. (1992). Human hematopoietic cells and thymic epithelial cells induce tolerance via different mechanisms in the SCID-hu mouse thymus. J. Exp. Med. 175, 1033-1043.
35. von Schwedler, U., Song, J., Aiken, C., and Trono, D. (1993). Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells. J. Virol. 67, 4945-4955.
36. Weinberg, J.B., Matthews, T.J., Cullen, B.R., and Malim, M.H. (1991). Productive human immunodeficiency virus type 1 (HIV-1) infection of nonproliferating human monocytes. J. Exp. Med. 174, 1477-1482.
37. Zack, J.A., Cann, A.J., Lugo, J.P., and Chen, I.S. (1988). HIV-1 production from infected peripheral blood T cells after HTLV-I induced mitogenic stimulation. Science 240, 1026-1029.
38. Zack, J.A., Arrigo, S.J., Weitsman, S.R., Go, A.S., Haislip, A., and Chen, I.S. (1990). HIV-1 entry into quiescent primary lymphocytes: molecular analysis. Cell 61, 213-222.
39. Zack, J.A., Haislip, A.M., Krogstad, P., and Chen, I.S. (1992). Incompletely reverse-transcribed human immunodeficiency virus type 1 genomes in quiescent cells can function as intermediates in the retroviral life cycle. J. Virol. 66, 1717-1725.
40. Zagury, D., Bernard, J., Leonard, R., Cheynier, R., Feldman, M., Sarin, P.S., and Gallo, R.C. (1986). Long-term cultures of HTLV-III - infected T cells: a model of cytopathology of T-cell depletion in AIDS. Science 237, 850-853.